Cormorant Asset Management’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-620,300
| Closed | -$8.9M | – | 54 |
|
|
2017
Q2 | $8.9M | Hold |
620,300
| – | – | 1.48% | 22 |
|
|
2017
Q1 | $13.1M | Buy |
620,300
+101,210
| +19% | +$2.14M | 1.9% | 20 |
|
|
2016
Q4 | $14.6M | Sell |
519,090
-57,016
| -10% | -$1.6M | 1.97% | 16 |
|
|
2016
Q3 | $15.4M | Hold |
576,106
| – | – | 1.7% | 21 |
|
|
2016
Q2 | $9.73M | Buy |
576,106
+6,976
| +1% | +$118K | 1.38% | 25 |
|
|
2016
Q1 | $12.1M | Hold |
569,130
| – | – | 1.82% | 20 |
|
|
2015
Q4 | $13.1M | Hold |
569,130
| – | – | 1.56% | 23 |
|
|
2015
Q3 | $11.4M | Hold |
569,130
| – | – | 1.82% | 17 |
|
|
2015
Q2 | $16.4M | Buy |
569,130
+350,000
| +160% | +$10.1M | 2.19% | 15 |
|
|
2015
Q1 | $6.7M | Sell |
219,130
-3,070
| -1% | -$93.9K | 1.04% | 30 |
|
|
2014
Q4 | $3.63M | Buy |
+222,200
| New | +$3.63M | 0.56% | 41 |
|